Heated committee hearing on hemp‑derived THC bill exposes deep splits over public safety, zoning and fairness; release fails

Representative Lynn presented House Bill 401, a sweeping measure to regulate sales of intoxicating hemp‑derived cannabinoid products (HDCPs) through a new retail license under the Office of the Marijuana Commissioner, mandatory testing and labeling, 21+ age‑verification at point of sale, sealed packaging, a 10‑milligram delta‑9 THC per‑serving cap and a 6% excise tax that the sponsor estimated could generate $35–40 million annually.

The bill prompted extensive committee questioning about several recurring issues: whether the bill’s preemption language would strip counties and municipalities of zoning control; whether the proposal creates a second‑class regulatory track that would undermine licensed recreational cannabis operators (who face stricter testing, zoning and build‑out costs); whether enforcement authority and inspection/seizure powers were clearly granted to the Division of Alcohol Tobacco Enforcement (DATE) and to the Office of the Marijuana Commissioner (OMC); and whether background‑check and criminal‑history provisions were stringent enough.

Rebecca Goldsmith, deputy secretary of finance, told the committee the draft contained technical and operational concerns including the need to integrate any excise tax into Delaware’s Title 30 tax‑administration framework and that implementing the bill may require additional auditors and system modifications.

Public comment divided the room. Supporters — including operators of existing hemp retailers and the Delaware Cannabis Advocacy Network — argued the bill gives consumers protections, brings unregulated businesses into a taxed, tested market and preserves jobs. Opponents argued it would grant a low‑cost pathway for legacy smoke shops that previously sold intoxicating hemp to obtain licenses at a lower barrier than regulated cannabis licensees, disadvantaging social‑equity license holders that invested to comply with OMC rules.

Law enforcement and DATE submitted concerns saying the bill as drafted did not clearly authorize inspections, seizures or other enforcement necessary to oversee the market, and warned that focusing on delta‑9 THC alone leaves other intoxicating cannabinoids (delta‑8, THCP, THCA) unaddressed. Marijuana Commissioner Josh Sanderland cautioned the bill could create two regulatory tracks for the same cannabinoid and highlighted federal changes that may affect interstate hemp commerce.

After extended debate and multiple motions, the committee held a roll call on a motion to release HB 401. The chair announced the bill "has not received the required number of votes" and said he would speak with members and seek bill backers; the committee adjourned for the day without releasing the measure.